Scarica l'app Stockscreener
0.2546
7.70%
0.0182
Precedente Chiudi:
$0.2364
Aprire:
$0.238
Volume 24 ore:
649.75K
Relative Volume:
0.28
Capitalizzazione di mercato:
$30.35M
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
+10.22%
1M Prestazione:
-19.94%
6M Prestazione:
+0.00%
1 anno Prestazione:
+0.00%
Intervallo 1D:
$0.23
$0.265
Intervallo di 1 settimana:
$0.215
$0.265
Portata 52W:
$0.205
$6.43
Pomdoctor Ltd Adr Stock (POM) Company Profile
Nome
Pomdoctor Ltd Adr
Settore
Industria
Telefono
-
Indirizzo
-
Compare POM vs HITI, PETS, WGRX, RDGT
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
POM
Pomdoctor Ltd Adr
|
0.2546 | 28.18M | 0 | 0 | 0 | 0.00 |
|
HITI
High Tide Inc
|
2.31 | 202.91M | 376.07M | -22.41M | 18.73M | -0.298 |
|
PETS
Petmed Express Inc
|
3.18 | 62.70M | 270.52M | -6.08M | 17.42M | -0.2944 |
|
WGRX
Wellgistics Health Inc
|
0.2788 | 28.76M | 28.99M | -39.20M | -3.34M | 0.00 |
|
RDGT
Ridgetech Inc
|
1.42 | 30.90M | 119.97M | -1.45M | 632.50K | -0.9847 |
Pomdoctor Ltd Adr Borsa (POM) Ultime notizie
POM SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Reminds Pomdoctor (POM) Investors of Securities Class Action Deadline on April 13, 2026 - GlobeNewswire Inc.
POM Investors Have Opportunity to Lead PomDoctor Ltd. Securities Fraud Lawsuit - Barchart.com
Shareholders who lost money in American Depositary Receipts of PomDoctor, Ltd. (NASDAQ: POM) Should Contact Wolf Haldenstein Immediately - ChartMill
POM SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Pomdoctor (POM) Investors of Securities Class Action Deadline on April 6, 2026 - Sahm
Shareholders who lost money in American Depositary Receipts - GlobeNewswire
Investor Notice: Shareholder Rights Law Firm Robbins LLP Informs Investors of the POMDoctor Ltd. Securities Class Action Lawsuit - ChartMill
ROSEN, LEADING INVESTOR COUNSEL, Encourages PomDoctor Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action - GlobeNewswire Inc.
Rosen Law Firm Urges PomDoctor Ltd. (NASDAQ: POM) Stockholders to Contact the Firm for Information About Their Rights - ChartMill
Scott+Scott Attorneys at Law LLP Files Securities Class Action Against PomDoctor, Ltd. (NASDAQ: POM) - ChartMill
Pomdoctor Deepens Medical Insurance Integration to Expand Online Chronic-Care Reach Across Major Chinese Cities - TipRanks
POM SHAREHOLDER ACTION: Faruqi & Faruqi, LLP Reminds Pomdoctor (POM) Investors of Securities Class Action Deadline on April 6, 2026 - Barchart.com
Pomdoctor Receives Nasdaq Deficiency Notice Over Minimum Bid Price - TipRanks
Pomdoctor expands online hospital business through pharma partnerships By Investing.com - Investing.com India
Pomdoctor Deepens Pharma Partnerships to Drive Internet Hospital Expansion in China - TipRanks
United States shares higher at close of trade; Dow Jones Industrial Average up 1.05% - Investing.com India
U.S. shares higher at close of trade; Dow Jones Industrial Average up 1.05% - Investing.com UK
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 1.05% - Investing.com
Pomdoctor (POM) Losses Persist as Price-to-Sales Premium Tests Bullish Scaling Narrative - Sahm
Pomdoctor Limited Reports Strong Revenue Growth Amidst Challenging Conditions - TipRanks
Legence, Cidara Therapeutics, Avadel Pharmaceuticals, Omeros And Other Big Stocks Moving Higher On Friday - Benzinga
Citi (NYSE: C) extends Token Services in Dublin with Euro transfers, 24/7 liquidity - Stock Titan
Citi (NYSE: C) lowers base lending rate to 7.00%, effective Oct 30 at Citibank, N.A. - Stock Titan
Diluted shares outstanding of PomDoctor Ltd. Unsponsored ADR – BOATS:POM - TradingView
Citi Appointed as Depositary Bank for POMDOCTOR LIMITED’s ADR Program - The AI Journal
Citigroup (NYSE:C) Stock Quote - FinancialContent
Free cash flow per share of PomDoctor Ltd. Unsponsored ADR – NASDAQ:POM - TradingView
Citigroup Reports Third Quarter 2025 Results - Business Wire
Q3 2025 Results: Citigroup Reports Results; Webcast & Conference Call at 11 a.m. ET Today - Stock Titan
Earnings calendar for: - Yahoo
$0.60 Quarterly Dividend: Citigroup to Pay Nov 26; Multiple Preferred Series Payments Announced - Stock Titan
Debt to assets ratio of PomDoctor Ltd. Unsponsored ADR – BOATS:POM - TradingView
Gross margin % of PomDoctor Ltd. Unsponsored ADR – BOATS:POM - TradingView
PomDoctor Ltd. Unsponsored ADR Balance Sheet – BOATS:POM - TradingView
Operating margin % of PomDoctor Ltd. Unsponsored ADR – BOATS:POM - TradingView
Diluted earnings per share (Diluted EPS) of PomDoctor Ltd. Unsponsored ADR – BOATS:POM - TradingView
PomDoctor Ltd. Unsponsored ADR Income Statement – BOATS:POM - TradingView
PomDoctor Ltd. Unsponsored ADR Statistics – BOATS:POM - TradingView
Diluted net income available to common stockholders of PomDoctor Ltd. Unsponsored ADR – NASDAQ:POM - TradingView
PomDoctor Ltd. Unsponsored ADR Financial Statements – BOATS:POM - TradingView
EBIT of PomDoctor Ltd. Unsponsored ADR – NASDAQ:POM - TradingView
Diluted earnings per share (Diluted EPS) of PomDoctor Ltd. Unsponsored ADR – NASDAQ:POM - TradingView
Total assets of PomDoctor Ltd. Unsponsored ADR – NASDAQ:POM - TradingView
PomDoctor Ltd. Unsponsored ADR Earnings and Revenue – BOATS:POM - TradingView
PomDoctor Ltd. Unsponsored ADR Revenue Breakdown – BOATS:POM - TradingView
Gross profit of PomDoctor Ltd. Unsponsored ADR – NASDAQ:POM - TradingView
Operating expenses (excl. COGS) of PomDoctor Ltd. Unsponsored ADR – NASDAQ:POM - TradingView
EBITDA of PomDoctor Ltd. Unsponsored ADR – NASDAQ:POM - TradingView
Should You Buy POM Stock After The PomDoctor IPO? - Barchart.com
Pomdoctor Limited (POM) Stock Price, News, Quote & History - Yahoo
Cash from financing activities of PomDoctor Ltd. Unsponsored ADR – NASDAQ:POM - TradingView
Number of employees of PomDoctor Ltd. Unsponsored ADR – NASDAQ:POM - TradingView
Pomdoctor Ltd Adr Azioni (POM) Dati Finanziari
Non sono disponibili dati finanziari per Pomdoctor Ltd Adr (POM). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
0.85%
0.58%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):